Spain · Delayed Price · Currency is EUR Cirsa Enterprises Statistics
Total Valuation
BME:CIRSA has a market cap or net worth of EUR 2.25 billion. The enterprise value is 4.18 billion.
| Market Cap | 2.25B |
| Enterprise Value | 4.18B |
Important Dates
The next estimated earnings date is Thursday, April 2, 2026.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:CIRSA has 167.99 million shares outstanding. The number of shares has increased by 119.61% in one year.
| Current Share Class | 167.99M |
| Shares Outstanding | 167.99M |
| Shares Change (YoY) | +119.61% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 2.13% |
| Float | 36.29M |
Valuation Ratios
The trailing PE ratio is 28.51 and the forward PE ratio is 8.01. BME:CIRSA's PEG ratio is 0.36.
| PE Ratio | 28.51 |
| Forward PE | 8.01 |
| PS Ratio | 0.96 |
| PB Ratio | 2.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.72 |
| P/OCF Ratio | 3.26 |
| PEG Ratio | 0.36 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.55, with an EV/FCF ratio of 8.78.
| EV / Earnings | 57.37 |
| EV / Sales | 1.79 |
| EV / EBITDA | 5.55 |
| EV / EBIT | 10.75 |
| EV / FCF | 8.78 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 2.69.
| Current Ratio | 0.89 |
| Quick Ratio | 0.83 |
| Debt / Equity | 2.69 |
| Debt / EBITDA | 2.95 |
| Debt / FCF | 4.61 |
| Interest Coverage | 1.71 |
Financial Efficiency
Return on equity (ROE) is 23.04% and return on invested capital (ROIC) is 9.20%.
| Return on Equity (ROE) | 23.04% |
| Return on Assets (ROA) | 6.28% |
| Return on Invested Capital (ROIC) | 9.20% |
| Return on Capital Employed (ROCE) | 11.84% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 148,373 |
| Profits Per Employee | 4,626 |
| Employee Count | 15,766 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 29.43 |
Taxes
In the past 12 months, BME:CIRSA has paid 68.39 million in taxes.
| Income Tax | 68.39M |
| Effective Tax Rate | 36.78% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 14.28 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 40.08 |
| Average Volume (20 Days) | 95,206 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:CIRSA had revenue of EUR 2.34 billion and earned 72.94 million in profits. Earnings per share was 0.47.
| Revenue | 2.34B |
| Gross Profit | 1.92B |
| Operating Income | 382.06M |
| Pretax Income | 185.95M |
| Net Income | 72.94M |
| EBITDA | 746.55M |
| EBIT | 382.06M |
| Earnings Per Share (EPS) | 0.47 |
Balance Sheet
The company has 372.23 million in cash and 2.20 billion in debt, with a net cash position of -1.83 billion or -10.87 per share.
| Cash & Cash Equivalents | 372.23M |
| Total Debt | 2.20B |
| Net Cash | -1.83B |
| Net Cash Per Share | -10.87 |
| Equity (Book Value) | 817.98M |
| Book Value Per Share | 4.58 |
| Working Capital | -70.94M |
Cash Flow
In the last 12 months, operating cash flow was 691.57 million and capital expenditures -214.93 million, giving a free cash flow of 476.64 million.
| Operating Cash Flow | 691.57M |
| Capital Expenditures | -214.93M |
| Depreciation & Amortization | 364.50M |
| Net Borrowing | -521.74M |
| Free Cash Flow | 476.64M |
| FCF Per Share | 2.84 |
Margins
Gross margin is 81.94%, with operating and profit margins of 16.33% and 3.12%.
| Gross Margin | 81.94% |
| Operating Margin | 16.33% |
| Pretax Margin | 7.95% |
| Profit Margin | 3.12% |
| EBITDA Margin | 31.91% |
| EBIT Margin | 16.33% |
| FCF Margin | 20.38% |
Dividends & Yields
BME:CIRSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 60.64% |
| Buyback Yield | -119.61% |
| Shareholder Yield | -119.61% |
| Earnings Yield | 3.24% |
| FCF Yield | 21.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:CIRSA has an Altman Z-Score of 1.42 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.42 |
| Piotroski F-Score | 8 |